These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29251330)
1. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway. Jiang W; Huang S; Song L; Wang Z Oncol Rep; 2018 Feb; 39(2):834-842. PubMed ID: 29251330 [TBL] [Abstract][Full Text] [Related]
2. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma. Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289 [TBL] [Abstract][Full Text] [Related]
3. Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients. Akhtar J; Wang Z; Jiang WP; Bi MM; Zhang ZP J Gastroenterol Hepatol; 2014 May; 29(5):944-50. PubMed ID: 24372619 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma. Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594 [TBL] [Abstract][Full Text] [Related]
5. TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy. Sun Z; Liu X; Song JH; Cheng Y; Liu Y; Jia Y; Meltzer SJ; Wang Z Tumour Biol; 2016 Aug; 37(8):10923-34. PubMed ID: 26886285 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway. Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594 [TBL] [Abstract][Full Text] [Related]
7. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway. Zhao H; Yang J; Fan T; Li S; Ren X Tumour Biol; 2012 Oct; 33(5):1363-74. PubMed ID: 22477709 [TBL] [Abstract][Full Text] [Related]
8. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888 [TBL] [Abstract][Full Text] [Related]
9. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma. Wang S; Akhtar J; Wang Z Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168 [TBL] [Abstract][Full Text] [Related]
10. [Expression of stathmin in esophageal squamous cell carcinoma and its biological significance]. Wang F; Wang LX; He W; Zhu LN; Zhao PR; Fan QX Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1552-7. PubMed ID: 20650764 [TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma]. Zhang Y; Liu YP; Du K; Wang H; Wang XL Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219 [TBL] [Abstract][Full Text] [Related]
12. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo. Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353 [TBL] [Abstract][Full Text] [Related]
13. Rho/ROCK Pathway Regulates Migration and Invasion of Esophageal Squamous Cell Carcinoma by Regulating Caveolin-1. Liu Z; Yu J; Wu R; Tang S; Cai X; Guo G; Chen S Med Sci Monit; 2017 Dec; 23():6174-6185. PubMed ID: 29288243 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
15. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
16. RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling. Xiao Z; Tian Y; Jia Y; Shen Q; Jiang W; Chen G; Shang B; Shi M; Wang Z; Zhao X Oncol Rep; 2020 Apr; 43(4):1289-1299. PubMed ID: 32323849 [TBL] [Abstract][Full Text] [Related]
17. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma. Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433 [TBL] [Abstract][Full Text] [Related]
18. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. Shi M; Chen D; Yang D; Liu XY J Exp Clin Cancer Res; 2015 Dec; 34():149. PubMed ID: 26667143 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233 [TBL] [Abstract][Full Text] [Related]
20. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]